Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Feb 9;10(2):74.
doi: 10.3390/jcdd10020074.

Artificial Intelligence in Hypertension Management: An Ace up Your Sleeve

Affiliations
Review

Artificial Intelligence in Hypertension Management: An Ace up Your Sleeve

Valeria Visco et al. J Cardiovasc Dev Dis. .

Abstract

Arterial hypertension (AH) is a progressive issue that grows in importance with the increased average age of the world population. The potential role of artificial intelligence (AI) in its prevention and treatment is firmly recognized. Indeed, AI application allows personalized medicine and tailored treatment for each patient. Specifically, this article reviews the benefits of AI in AH management, pointing out diagnostic and therapeutic improvements without ignoring the limitations of this innovative scientific approach. Consequently, we conducted a detailed search on AI applications in AH: the articles (quantitative and qualitative) reviewed in this paper were obtained by searching journal databases such as PubMed and subject-specific professional websites, including Google Scholar. The search terms included artificial intelligence, artificial neural network, deep learning, machine learning, big data, arterial hypertension, blood pressure, blood pressure measurement, cardiovascular disease, and personalized medicine. Specifically, AI-based systems could help continuously monitor BP using wearable technologies; in particular, BP can be estimated from a photoplethysmograph (PPG) signal obtained from a smartphone or a smartwatch using DL. Furthermore, thanks to ML algorithms, it is possible to identify new hypertension genes for the early diagnosis of AH and the prevention of complications. Moreover, integrating AI with omics-based technologies will lead to the definition of the trajectory of the hypertensive patient and the use of the most appropriate drug. However, AI is not free from technical issues and biases, such as over/underfitting, the "black-box" nature of many ML algorithms, and patient data privacy. In conclusion, AI-based systems will change clinical practice for AH by identifying patient trajectories for new, personalized care plans and predicting patients' risks and necessary therapy adjustments due to changes in disease progression and/or therapy response.

Keywords: artificial intelligence; big data; blood pressure; deep learning; deep neural networks; digital health; hypertension; machine learning; photoplethysmograph; wearable technology.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
The typical ML workflow in healthcare research.
Figure 2
Figure 2
Block diagram of the blood pressure estimation process using ML techniques. In detail, the raw signals are prepared through normalization, the correction of baseline wandering due to respiration, and finally, signal filtration. Specifically, to construct a dataset for BP estimation models, it is necessary to accurately extract the features of the original waveform (and underlying demographic and statistical data) and select effective features, improving the generalization and reducing the risk of overfitting the algorithms. PPG: photoplethysmograph; ML: machine learning.

References

    1. Sorriento D., Rusciano M.R., Visco V., Fiordelisi A., Cerasuolo F.A., Poggio P., Ciccarelli M., Iaccarino G. The Metabolic Role of GRK2 in Insulin Resistance and Associated Conditions. Cells. 2021;10:167. doi: 10.3390/cells10010167. - DOI - PMC - PubMed
    1. Visco V., Finelli R., Pascale A.V., Giannotti R., Fabbricatore D., Ragosa N., Ciccarelli M., Iaccarino G. Larger Blood Pressure Reduction by Fixed-Dose Compared to Free Dose Combination Therapy of ACE Inhibitor and Calcium Antagonist in Hypertensive Patients. Transl. Med. UniSa. 2017;16:17–23. - PMC - PubMed
    1. NCD Risk Factor Collaboration Worldwide trends in blood pressure from 1975 to 2015: A pooled analysis of 1479 population-based measurement studies with 19.1 million participants. Lancet. 2017;389:37–55. doi: 10.1016/S0140-6736(16)31919-5. - DOI - PMC - PubMed
    1. Izzo C., Vitillo P., Di Pietro P., Visco V., Strianese A., Virtuoso N., Ciccarelli M., Galasso G., Carrizzo A., Vecchione C. The Role of Oxidative Stress in Cardiovascular Aging and Cardiovascular Diseases. Life. 2021;11:60. doi: 10.3390/life11010060. - DOI - PMC - PubMed
    1. Whitworth J.A., World Health Organization. International Society of Hypertension Writing Group 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J. Hypertens. 2003;21:1983–1992. doi: 10.1097/00004872-200311000-00002. - DOI - PubMed

LinkOut - more resources